[Production of antirickettsial sera by immunizing horses. II. Obtaining and testing an immune serum to D. sibericus].

The research article describes a process of immunizing horses with a combination of commercial antigen and R. sibericus (strain K1) to produce specific immune sera, which can be used for various medical purposes. The sera produced after primary immunization are reportedly suitable for diagnostics, with further sera obtained after reimmunization having more universal applications.

Immunization of Horses

• The central process of this research is the immunization of horses with a blend of commercial antigen and the yolk culture of R. sibericus, a bacteria strain.
• This method is intended to produce antigen-specific immune sera, which can potentially be beneficial for various medical and research purposes.

Immunization Scheme Efficiency

• The study also verifies the efficacy of a ‘combined scheme’ of immunization and reimmunization which previously proved successful in preparing immune sera against another bacteria, Rickettsia prowazeki.
• This scheme is shown to be equally successful for procuring the antisera for R. sibericus as well.

Primary vs. Remote Reimmunization

• The sera obtained after the primary immunization were found useful for diagnostic purposes but were not adequate for creating fluorescent antibodies or a highly active hemosensitin.
• In contrast, sera acquired after further or ‘remote’ reimmunization were identified as universal raw material, indicating higher efficacy and broad applicability.

Production of Antigen-Specific Products

• The results of the study indicate that dry fluorescent antibodies specific to R. sibericus could be prepared from the immunized horse sera, with their stain titre ranging between 1 : 256–1 : 512.
• A powerfully active product called hemosensitin was also formulated from the sera, along with dry commercial diagnostic sera meant for several diagnostic tests like Indirect Hemagglutination Test (IHT), Complement Fixation Reaction (CFR) and the immunofluorescent reaction of microagglutination.